ArticleDigestive diseases and sciences2026
Clinical Insights on "Tolerability and Effectiveness of Glucagon‑Like Peptide‑1 Receptor Agonists in Patients with Inflammatory Bowel Disease".
XiRui Yang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.